Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Bayer to Run Corrective Ad for Birth-Control Pill
PharmExec, 02/19/09
Bayer, last week, launched a $20 million “make-good” campaign for its birth-control pill Yaz. Rather than talk up the benefits of the drug, the commercial states bluntly, “You may have seen some Yaz commercials recently that were not clear. The FDA wants us to correct a few points in those ads.”
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09
Mediware Makes Two Buys
HealthDataManagement, 12/10/09
Visanne cleared for market launch in Europe as new treatment option for endometriosis
BayNews International, 12/08/09
Article Search
Sponsor